What's happening with the ResMed share price on Wednesday?

The ResMed share price is facing some quarterly headwinds today.

| More on:
Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc (ASX: RMD) share price is edging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $29.30. In morning trade on Wednesday, shares are swapping hands for $29.34, up 0.1%.

For some context, the ASX 200 is up 0.6% at this same time.

Here's what's happening.

What's going on with the ASX 200 healthcare company?

The ResMed share price may be trailing the ASX 200 because the sleep treatment company's stock is trading ex-dividend today.

That means investors who buy the stock today will no longer be eligible for the 4.8 US cents per share unfranked dividend.

That passive income payout will go to investors who held ResMed shares at market close yesterday. Eligible investors can expect to see this hit their bank accounts on 14 March.

The company will report on the Aussie dollar equivalent for ASX investors on Friday, 9 February. (At time of writing AU$1 is worth 65.3 US cents.)

It's common for stocks to face some headwinds on the day they trade ex-dividend. All else being equal, the ResMed share price is now factored in at 4.8 US cents less than it would have been yesterday.

Unlike most ASX 200 stocks, ResMed pays dividends on a quarterly basis.

In the quarter just past, the company paid US$70.7 million in dividends. It also repurchased 335,000 shares for US$50 million as part of ResMed's ongoing capital management.

Overall, it was a strong quarter for the company, with revenue up 12% year on year (11% on a constant currency basis) to US$1.2 billion. And profits were well up, with non-GAAP operating profit leaping 20%.

Commenting on the outlook for the sleep treatment company on the day it reported, CEO Mick Farrell said, "ResMed is well-positioned to lean into leading the expansion and growth of sleep health and breathing health. We are the clear leader in a very large and growing market."

ResMed share price snapshot

The steep falls in August and September see the ResMed share price down 7% over 12 months.

Shares have soared 37% since the lows on 25 September.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Dividend Investing

the australian flag lies alongside the united states flag on a flat surface.
Dividend Investing

Own VTS ETF? Here's your next dividend

Vanguard has announced the final distribution for VTS ETF investors.

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Dividend Investing

Beat low interest rates with these buy-rated ASX dividend stocks

Analysts expect these stocks to offer dividend yields that are better than bank interest rates.

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Dividend Investing

Forget term deposits! I'd buy these two ASX shares instead

These businesses have very impressive dividend records.

Read more »

Hand of a woman carrying a bag of money, representing the concept of saving money or earning dividends.
Dividend Investing

Why experts say these growing ASX dividend shares are top buys for income

Analysts have good things to say about these income options.

Read more »

Green arrow going up on a stock market chart, symbolising a rising share price.
Dividend Investing

1 ASX dividend stock down 30% I'd buy right now

This business looks far too cheap to me!

Read more »

A retiree relaxing in the pool and giving a thumbs up.
Dividend Investing

Time to buy this ASX dividend share now it's down 14%

Analysts foresee total returns, including share price gains and dividends, to exceed 25%.

Read more »

Australian notes and coins symbolising dividends.
Dividend Investing

1 impressively awesome Australian dividend stock down 20% to hold for decades!

This business looks far too cheap to me.

Read more »

Person handing out $50 notes, symbolising ex-dividend date.
Dividend Investing

Where I'd invest $10,000 into ASX dividend shares right now

I think these businesses are a strong buy for passive income.

Read more »